ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

Researchers at the Perelman School of Medicine identified over 1,000 genes that could serve as potential treatment targets for kidney disease in a newly published study. The study marks the most ...

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Kidney disease can cause facial swelling, itchiness, and blisters. Symptoms can depend on the stage of kidney disease. Uremic leontiasis ossea is a rare and severe complication of advanced kidney ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

FDA assigned PDUFA target action date of July 7, 2026.If approved, atacicept would be the first B cell modulator targeting ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.